Minimal clinically significant change for the International Restless Legs Syndrome Study Group rating scale in clinical trials is a score of 3.
Dept. of Neurology, Johns Hopkins Univ., Baltimore, MD, USA. Electronic address: richardjhu@mac.com.
Richard P
RP
Allen
D002986:Clinical Trials as Topic / Q000379:methods*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D012148:Restless Legs Syndrome / Q000188:drug therapy*; D012720:Severity of Illness Index
D018491:Dopamine Agonists